Pasithea Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pasithea Therapeutics Corp. (KTTA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents6.9216.3333.0952.970.24
Cash & Short-Term Investments6.9216.3333.0952.970.24
Accounts Receivable0.000.040.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.300.100.260.330.00
Total Current Assets7.3716.6934.0853.300.25
Non-Current Assets
Property, Plant & Equipment (Net)0.120.220.630.020.00
Goodwill1.261.261.260.000.00
Intangible Assets7.317.948.570.000.00
Other Non-Current Assets0.000.000.640.000.00
Total Non-Current Assets8.709.4211.100.020.00
Total Assets16.0626.1245.1853.320.25
Current Liabilities
Accounts Payable1.122.551.480.450.01
Other Current Liabilities0.000.000.240.000.00
Total Current Liabilities1.122.631.880.450.01
Non-Current Liabilities
Long-Term Debt0.000.000.340.000.00
Other Non-Current Liabilities0.160.080.461.450.00
Total Non-Current Liabilities0.160.080.801.450.00
Total Liabilities1.282.722.681.900.01
Stockholders' Equity
Common Stock0.000.000.000.020.01
Retained Earnings-49.58-35.32-19.36-2.21-0.04
Accumulated Other Comprehensive Income-0.010.000.00-0.010.00
Additional Paid-in Capital64.3758.7261.8653.630.00
Shares Outstanding1.391.041.301.150.00
Total Stockholders' Equity14.7823.4042.5051.420.24
Total Liabilities & Equity16.0626.1245.1853.320.00